Butorphanol dependence increases hippocampal κ-opioid receptor gene expression

Journal of Neuroscience Research

Volumn 82, Issue 2, 2005, Pages 255-263

  Tanaka, Sachiko ^a,b   Fan, Lir Wan ^b   Tien, Lu Tai ^b   Park, Younjoo ^b   Liu Chen, Lee Yuan ^c   Rockhold, Robin William ^b   Ho, Ing Kang ^b  

^a SHOWA UNIVERSITY   (Japan)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

opioid receptors; Butorphanol dependence; Butorphanol withdrawal; Immunoblotting; In situ hybridization; Reverse transcription polymerase chain reaction

Indexed keywords

BUTORPHANOL; MESSENGER RNA; OPIATE RECEPTOR;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENTION; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DEPENDENCE; GENE EXPRESSION; HIPPOCAMPUS; MALE; MESENCEPHALON; NONHUMAN; OSMOTIC PUMP; PARIETAL LOBE; PONS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; TEMPORAL CORTEX; THALAMUS; WESTERN BLOTTING;

ANIMALS; BRAIN; BUTORPHANOL; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; NARCOTICS; OPIOID-RELATED DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; RNA, MESSENGER; SUBSTANCE WITHDRAWAL SYNDROME; UP-REGULATION;

EID: 27844456829     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20620     Document Type: Article

References (43)

1. Brown GR. 1985. Stadol dependence: another case. JAMA 254:910.
2. Castillo PE, Salin PA, Weisskopf MG, Nicoll RA. 1996. Characterizing the site and mode of action of dynorphin at hippocampal mossy fiber synapses in the guinea pig. J Neurosci 16:5942-5950.
3. Caudle RM, Chavkin C, Dubner R. 1994. Kappa 2 opioid receptors inhibit NMDA receptor-mediated synaptic currents in guinea pig CA3 pyramidal cells. J Neurosci 14:5580-5589.
4. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
5. Christie MJ, Williams JT, Osborne PB, Bellchambers CE. 1997. Where is the locus in opioid withdrawal? Trends Pharmacol Sci 18:134-140.
6. Cuello AC. 1983. Brain microdissection techniques. New York: John Wiley & Sons.
7. Devine DP, Wise RA. 1994. Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci 14:1978-1984.
8. Evans WS, Bowen JN, Giordano FL, Clark B. 1985. A case of stadol dependence. JAMA 253:2191-2192.
9. 2-opioid receptor binding. Brain Res 958:277-290.
10. 1-opioid receptor binding in the rat brain. Brain Res Bull 58:149-160.
11. Fan LW, Tien LT, Tanaka S, Ma T, Chudapongse N, Sinchaisuk S, Rockhold RW, Ho IK. 2003a. Withdrawal from depedence upon butorphanol uniquely changes κ-opioid receptor protein levels in the rat brain. Neuroscience 121:1063-1074.
12. Fan LW, Tien LT, Tanaka S, Sasaki K, Park Y, Ma T, Rockhold RW, Ho IK. 2003b. Enhanced binding of nor-binaltorphimine to κ-opioid receptors in rats dependent upon butorphanol. J Neurosci Res 72:781-789.
13. George SR, Zastawny RW, Briones-Urbina R, Cheng R, Nguyen T, Heiber M, Kouvelas A, Chan AS, O Dowd BF. 1994. Distinct distributions of mu, delta and kappa opioid receptor mRNA in rat brain. Biochem Biophys Res Commun 205:1438-1444.
14. Glowinski J, Iversen L. 1966. Regional studies of catecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions. Biochem Pharmacol 15:977-987.
15. Heimer L, Zahm DS, Alheid GF. 1995. Basal ganglia. In: Paxinos G, editor. The rat nervous system. San Diego: Academic Press. p 579-628.
16. Ho IK, Feng YZ, Tokuyama S, Hoshi K, Rockhold RW. 1997. Glutamate in opioid dependence. Nihon Shinkei Seishin Yakurigaku Zasshi 17:175-180.
17. Horan P, Ho IK. 1991. The physical dependence liability of butorphanol: a comparative study with morphine. Eur J Pharmacol 203:387-391.
18. 3H]MK-801 binding during butorphanol withdrawal in the rat brain. Brain Res 845:236-241.
19. Jaw SP, Hoskins B, Ho IK. 1993a. Opioid antagonists and butorphanol dependence. Pharmacol Biochem Behav 44:497-500.
20. Jaw SP, Makimura M, Hoskins B, Ho IK. 1993b. Effects of nor-binaltorphimine on butorphanol dependence. Eur J Pharmacol 239:133-140.
21. Joshi SK, Su X, Porreca F, Gebhart GF. 2000. Kappa-opioid receptor agonists modulate visceral nociception at a novel, peripheral site of action. J Neurosci 20:5874-5879.
22. Kitchen I, Slowe SJ, Matthes HW, Kieffer B. 1997. Quantitative autoradiographic mapping of mu-, delta- and kappa-opioid receptors in knockout mice lacking the mu-opioid receptor gene. Brain Res 778:73-88.
23. Koob GF. 1992. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
24. Koob GF, Le Moal M. 1997. Drug abuse: hedonic homeostatic dysregulation. Science 278:52-58.
25. Koob GF, Maldonado R, Stinus L. 1992. Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191.
26. Li S, Zhu J, Chen C, Chen YW, Deriel JK, Ashby B, Liu-Chen LY. 1993. Molecular cloning and expression of a rat kappa opioid receptor. Biochem J 295:629-633.
27. Maldonado R, Stinus L, Gold LH, Koob GF. 1992. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669-677.
28. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ. 1994. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350:412-438.
29. Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H. 1993. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proc Natl Acad Sci U S A 90:9954-9958.
30. Minami M, Toya T, Katao Y, Maekawa K, Nakamura S, Onogi T, Kaneko S, Satoh M. 1993. Cloning and expression of a cDNA for the rat kappa-opioid receptor. FEBS Lett 329:291-295.
31. Mulder AB, Hodenpijl MG, Lopes da Silva FH. 1998. Electrophysiology of the hippocampal and amygdaloid projections to the nucleus accumbens of the rat: convergence, segregation, and interaction of inputs. J Neurosci 18:5095-5102.
32. Palkovits M, Brownstein MJ. 1988. Maps and guide to microdissection of the rat brain. New York: Elsevier.
33. 35]GTPgammaS binding in butorphanol continuously infused rat. Brain Res Bull 52:17-20.
34. th ed. San Diego: Academic Press.
35. Pircio AW, Gylys JA, Cavanagh RL, Buyniski JP, Bierwagen ME. 1976. The pharmacology of butorphanol, a 3,14-dihydroxymorphinan narcotic antagonist analgesic. Arch Int Pharmacodyn Ther 220:231-257.
36. Rockhold RW, Liu N, Coleman D, Commiskey S, Shook J, Ho IK. 2000. The nucleus paragigantocellularis and opioid withdrawal-like behavior. J Biomed Sci 7:270-276.
37. Self DW, Nestler EJ. 1995. Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18:463-495.
38. Unterwald EM, Knapp C, Zukin RS. 1991. Neuroanatomical localization of kappa 1 and kappa 2 opioid receptors in rat and guinea pig brain. Brain Res 562:57-65.
39. Weisskopf MG, Zalutsky RA, Nicoll RA. 1993. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 365:188.
40. Williams JT, Christie MJ, Manzoni O. 2001. Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343.
41. Wise RA. 1996. Addictive drugs and brain stimulation reward. Annu Rev Neurosci 19:319-340.
42. Wongchanapai W, Tsang BK, He Z, Ma T, Ho IK. 1998. Supersensitivity of spinal opioid receptors to antagonists in intrathecal butorphanol and morphine dependence. Life Sci 63:2175-2180.
43. Woods JH, Gmerek DE. 1985. Substitution and primary dependence studies in animals. Drug Alcohol Depend 14:233-247.